Linked Life Data

17244173

Source:http://linkedlifedata.com/resource/pubmed/id/17244173

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2007-1-24
pubmed:abstractText
This study sought to examine the effectiveness of sibutramine, a weight loss agent, on clozapine-associated weight gain.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0001-690X
pubmed:author
pubmed:issnType
Print
pubmed:volume
115
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
101-5
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:17244173-Adult, pubmed-meshheading:17244173-Anthropometry, pubmed-meshheading:17244173-Antipsychotic Agents, pubmed-meshheading:17244173-Appetite Depressants, pubmed-meshheading:17244173-Blood Glucose, pubmed-meshheading:17244173-Body Mass Index, pubmed-meshheading:17244173-Body Weight, pubmed-meshheading:17244173-Cholesterol, pubmed-meshheading:17244173-Clozapine, pubmed-meshheading:17244173-Cyclobutanes, pubmed-meshheading:17244173-Double-Blind Method, pubmed-meshheading:17244173-Fasting, pubmed-meshheading:17244173-Female, pubmed-meshheading:17244173-Hemoglobin A, Glycosylated, pubmed-meshheading:17244173-Hemoglobins, pubmed-meshheading:17244173-Humans, pubmed-meshheading:17244173-Male, pubmed-meshheading:17244173-Obesity, pubmed-meshheading:17244173-Psychotic Disorders, pubmed-meshheading:17244173-Schizophrenia, pubmed-meshheading:17244173-Weight Gain
pubmed:year
2007
pubmed:articleTitle
A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain.
pubmed:affiliation
The Schizophrenia Program, Massachusetts General Hospital, Boston, MA, USA. dchenderson@partners.org
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't